FT576 (Allogenic CAR NK cells with BCMA expression)
FT576-101
Phase 1 small_molecule completed
Quick answer
FT576 (Allogenic CAR NK cells with BCMA expression) for Multiple Myeloma is a Phase 1 program (small_molecule) at FATE THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- FATE THERAPEUTICS INC
- Indication
- Multiple Myeloma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed